MedTrace Logo

To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions

NCT00913952 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2017-03-28

No results posted yet for this study

Summary

To demonstrate the relative bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride capsules under fed and fasted conditions.

Conditions

Interventions

DRUG

Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions

DRUG

Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions

DRUG

Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions

Sponsors & Collaborators

Principal Investigators

  • Richard Lalonde, Pharm.D. · Phoenix International Life Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1994-04-30
Primary Completion
1994-06-30
Completion
1994-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913952 on ClinicalTrials.gov